Featuring an interview with Dr Steven Horwitz, including the following topics:
- Overview of peripheral T-cell lymphomas (PTCLs) (0:00)
- Efficacy and safety of brentuximab vedotin in the management of treatment-naïve and relapsed PTCLs (9:57)
- Emerging therapeutic strategies for PTCLs (19:48)
- Case: A man in his early 50s with CD30-positive anaplastic large cell lymphoma who experienced complete response (CR) to BV-CHP and continued remission after consolidation with autologous stem cell transplant (ASCT) (25:53)
- Management of ALK-positive anaplastic large cell lymphoma (32:14)
- Case: A man in his late 50s with CD8-positive PTCL not otherwise specified who achieved CR with CHOEP and experienced relapse after ASCT (34:33)
- Case: A woman in her early 70s with chemorefractory CD30-positive angioimmunoblastic T-cell lymphoma (38:26)
- Ongoing first-line studies for T-cell lymphomas; association of CAR T-cell therapy with T-cell malignancies (42:18)
CME information and select publications